Curocell Inc. (KOSDAQ:372320)

Curocell Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	4,581	9,917
Short-Term Investments	7,200	32,000
Cash & Short-Term Investments	11,781	41,917
Cash Growth	-71.90%	-
Other Receivables	8.85	608.84
Receivables	8.85	608.84
Prepaid Expenses	746.64	109.74
Other Current Assets	511.2	151.17
Total Current Assets	13,047	42,787
Property, Plant & Equipment	55,450	61,242
Long-Term Investments	1,500	-
Other Intangible Assets	1,471	520.99
Other Long-Term Assets	263.17	419.75
Total Assets	72,021	104,969
Accrued Expenses	330.32	254.7
Short-Term Debt	800	800
Current Portion of Long-Term Debt	34,390	-
Current Portion of Leases	494.11	502.31
Current Income Taxes Payable	1.18	-
Other Current Liabilities	2,736	1,713
Total Current Liabilities	38,751	3,270
Long-Term Debt	-	39,595
Long-Term Leases	1,616	2,020
Other Long-Term Liabilities	662.92	552.97
Total Liabilities	42,567	45,870
Common Stock	7,100	6,806
Additional Paid-In Capital	215,016	205,660
Retained Earnings	-199,095	-160,463
Comprehensive Income & Other	6,434	7,097
Shareholders' Equity	29,454	59,100
Total Liabilities & Equity	72,021	104,969
Total Debt	37,300	42,918
Net Cash (Debt)	-25,519	-1,000
Net Cash Per Share	-1826.04	-84.54
Filing Date Shares Outstanding	14.2	13.61
Total Common Shares Outstanding	14.2	13.61
Working Capital	-25,704	39,516
Book Value Per Share	2074.34	4341.49
Tangible Book Value	27,983	58,579
Tangible Book Value Per Share	1970.75	4303.22
Land	5,699	5,699
Buildings	23,310	23,423
Machinery	15,879	15,429
Construction In Progress	-	13.95

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.